References
1. World Health Organization
(WHO): What is a pandemic? Accessed on 2-2010). Found at:
https://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/.
2. Horimoto T, Kawaoka Y.
Influenza: lessons from past pandemics, warnings from current incidents.Nat Rev Microbiol. 2005;3:591-600. doi: 510.1038/nrmicro1208.
3. Morens DM, Taubenberger
JK. The Mother of All Pandemics Is 100 Years Old (and Going Strong)!Am J Public Health. 2018;108:1449-1454. doi:
1410.2105/AJPH.2018.304631. Epub 302018 Sep 304625.
4. Yang Y, Peng F, Wang R, et
al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel
coronavirus epidemic in China. J Autoimmun.2020;109:102434.:10.1016/j.jaut.2020.102434. Epub 102020 Mar 102433.
5. World Health Organization
(WHO): Rolling updates on coronavirus disease (COVID-19). Accessed on
5-2020. Found at:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
6. Sohrabi C, Alsafi Z,
O’Neill N, et al. Corrigendum to ”World Health Organization declares
Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)”
[Int. J. Surg. 76 (2020) 71-76]. Int J Surg. 2020;15:036.
7. Huang C, Wang Y, Li X, et
al. Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet. 2020;395:497-506.
8. Kandel N, Chungong S,
Omaar A, Xing J. Health security capacities in the context of COVID-19
outbreak: an analysis of International Health Regulations annual report
data from 182 countries. The Lancet.
9. Huang C, Wang Y, Li X, et
al. Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. The Lancet. 2020;395:497-506.
10. World Health
Organization. Coronavirus disease (COVID-19) advice for the public.
Accessed on 5-2020. Found at
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public.
11. Corkill NL. Epidemic
smallpox in Jiddah; treatment with antibiotics. Br Med J.1951;2:663-667. doi: 610.1136/bmj.1132.4732.1663.
12. Scrimgeour EM. Epidemic
infections and their relevance to the Gulf and other Arabian Peninsula
countries. J Sci Res Med Sci. 2003;5:1-4.
13. Memish ZA, Venkatesh S,
Ahmed QA. Travel epidemiology: the Saudi perspective. Int J
Antimicrob Agents. 2003;21:96-101. doi:
110.1016/s0924-8579(1002)00364-00363.
14. Basheti IA, Nassar R,
Barakat M, et al. Pharmacists’ readiness to deal with the coronavirus
pandemic: Assessing awareness and perception of roles. Res Social
Adm Pharm. 2020;23:30418-30416.
15. Sokolow LZ, Patel A,
Koonin LM, Graitcer SB. Scripted Surge Pharmacy Pandemic Exercise:
Testing Vaccine Administration and Antiviral Dispensing. Health
Secur. 2018;16:262-273. doi: 210.1089/hs.2018.0031.
16. Rosenfeld LA, Etkind P,
Grasso A, Adams AJ, Rothholz MC. Extending the reach: local health
department collaboration with community pharmacies in Palm Beach County,
Florida for H1N1 influenza pandemic response. J Public Health
Manag Pract. 2011;17:439-448. doi: 410.1097/PHH.1090b1013e31821138ae.
17. SteelFisher GK, Benson
JM, Caporello H, et al. Pharmacist Views on Alternative Methods for
Antiviral Distribution and Dispensing During an Influenza Pandemic.Health Secur. 2018;16:108-118. doi: 110.1089/hs.2017.0068. Epub
2018 Mar 1023.
18. Nazar Z, Nazar H.
Exploring the experiences and preparedness of humanitarian pharmacists
in responding to an emergency-response situation. Res Social Adm
Pharm. 2020;16:90-95. doi: 10.1016/j.sapharm.2019.1003.1146. Epub 2019
Mar 1031.
19. Song Z, Hu Y, Zheng S,
Yang L, Zhao R. Hospital pharmacists’ pharmaceutical care for
hospitalized patients with COVID-19: Recommendations and guidance from
clinical experience. Res Social Adm Pharm. 2020;3:30314-30314.
20. Khan Z, Muhammad K,
Ahmed A, Rahman H. Coronavirus outbreaks: prevention and management
recommendations. Drugs & Therapy Perspectives. 2020:1-3.
21. Gross AE, MacDougall C.
Roles of the clinical pharmacist during the COVID‐19 pandemic.Journal of the American colledge of clinical pharmacy 2020:1-3.
22. Miller S, Patel N,
Vadala T, Abrons J, Cerulli J. Defining the pharmacist role in the
pandemic outbreak of novel H1N1 influenza. J Am Pharm Assoc
(2003). 2012;52:763-767. doi: 710.1331/JAPhA.2012.11003.
23. McCourt E. Improving
pharmacist involvement in pandemic influenza planning and response in
Australia. Found at
https://ahha.asn.au/system/files/docs/publications/summary_deeble_institute_issues_brief_no._25.pdf.
Accessed 4, 2020. Australian Healthcare and Hospital Association.2018.
24. Zheng SQ, Yang L, Zhou
PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing
pharmaceutical care services during COVID-19 pandemic: A China
perspective. Res Social Adm Pharm. 2020;26:30284-30289.
25. WHO Coronavirus Disease
(COVID-19) Dashboard. Accessed on May-2020. Found at
https://covid19.who.int/.
26. Hernandez-Garcia I,
Gimenez-Julvez T. Assessment of Health Information About COVID-19
Prevention on the Internet: Infodemiological Study. JMIR Public
Health Surveill. 2020;6:e18717. doi: 18710.12196/18717.
27. Karasneh R, Al-Azzam S,
Muflih S, Soudah O, Hawamdeh S, Khader Y. Media’s effect on shaping
knowledge, awareness risk perceptions and communication practices of
pandemic COVID-19 among pharmacists. Res Social Adm
Pharm. :.10.1016/j.sapharm.2020.1004.1027.
28. Day M. Covid-19:
ibuprofen should not be used for managing symptoms, say doctors and
scientists. 2020;368:m1086.
29. FDA cautions against use
of hydroxychloroquine or chloroquine for COVID-19 outside of the
hospital setting or a clinical trial due to risk of heart rhythm
problems. Cited on 4-2020/ Available from:
https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or.
30. Sanders JM, Monogue ML,
Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus
Disease 2019 (COVID-19): A Review. Jama. 2020;13.
31. Le Bourgeois M, Ferroni
A, Leruez-Ville M, et al. Nonsteroidal Anti-Inflammatory Drug without
Antibiotics for Acute Viral Infection Increases the Empyema Risk in
Children: A Matched Case-Control Study. J Pediatr.2016;175:47-53.e3.:10.1016/j.jpeds.2016.1005.1025. Epub 2016 Jun 1020.
32. Capuano A, Scavone C,
Racagni G, Scaglione F. NSAIDs in patients with viral infections,
including Covid-19: victims or perpetrators? Pharmacol Res.2020;29:104849.
33. Alobaedi OH, Talib WH,
Basheti IA. Antitumor effect of thymoquinone combined with resveratrol
on mice transplanted with breast cancer. Asian Pac J Trop Med.2017;10:400-408. doi: 410.1016/j.apjtm.2017.1003.1026. Epub 2017 Apr
1017.
34. Lima CKT, Carvalho PMM,
Lima I, et al. The emotional impact of Coronavirus 2019-nCoV (new
Coronavirus disease). Psychiatry Res.2020;287:112915.:10.1016/j.psychres.2020.112915.
35. Walton M, Murray E,
Christian MD. Mental health care for medical staff and affiliated
healthcare workers during the COVID-19 pandemic. Eur Heart J Acute
Cardiovasc Care. 2020;28:2048872620922795.
36. FIP. Coronavirus
SARS-CoV-2 / COVID-19 pandemic: Information and Guidelines for
Pharmacists and the Pharmacy Workforce Vol 2020. The Netherlands:
International Pharmaceutical Federation 2020.
37. Nazer LH, Tuffaha H.
Health Care and Pharmacy Practice in Jordan. Can J Hosp Pharm.2017;70:150-155. doi: 110.4212/cjhp.v4270i4212.1649. Epub 2017 Apr 4228.
38. Tyrer S, Heyman B.
Sampling in epidemiological research: issues, hazards and pitfalls.BJPsych Bull. 2016;40:57-60. doi: 10.1192/pb.bp.1114.050203.
39. Nelson LM, Simard JF,
Oluyomi A, et al. US Public Concerns About the COVID-19 Pandemic From
Results of a Survey Given via Social Media. JAMA Intern Med.2020;7.
40. Bates I, Bader LR,
Galbraith K. A global survey on trends in advanced practice and
specialisation in the pharmacy workforce. Int J Pharm Pract.2020;28:173-181. doi: 110.1111/ijpp.12611.